FDA OKs emergency use of Thermo Fisher COVID-19 test

The FDA has issued its fourth Emergency Use Authorization (EUA) for coronavirus tests, this time to Thermo Fisher Scientific (NYSE:TMO) for its TaqPath COVID-19 Combo Kit.

The FDA says it authorized the test within 24 hours of receiving the company’s request. It is the second commercially distributed test to receive an EUA during the current outbreak (Roche’s was first).

https://seekingalpha.com/news/3551763-fda-oks-emergency-use-of-thermo-fisher-covidminus-19-test